News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Conference News ACC 2024 Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It Michael O'Riordan March 27, 2024
News Daily News ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain Todd Neale March 25, 2024
News Daily News US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users Caitlin E. Cox March 18, 2024
News Conference News THT 2024 Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring Michael O'Riordan March 11, 2024
News Daily News ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy Todd Neale March 11, 2024
News Conference News THT 2024 Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF Michael O'Riordan March 08, 2024
News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
Presentation THT Abstracts 2024 Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF) Presenter: Alexandra Steverson March 05, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
Presentation THT 2024 A Case of Severe De Novo HF on Support for 14 days Without Evidence of Recovery Presenter: Elena M. Donald March 04, 2024
Presentation THT 2024 FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities Presenter: Michael R. Zile March 04, 2024
News Daily News More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis L.A. McKeown February 12, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024